CSTL
Castle Biosciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$25.56
+0.24 ▲ +0.95%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$25.56
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -0.85 | Insider Own | 2.65% | Shs Outstand | 0.03B | Perf Week | -5.75% |
| Market Cap | 0.76B | Forward P/E | - | EPS next Y | 53.72% | Insider Trans | -21.41% | Shs Float | 0.03B | Perf Month | -20.96% |
| Enterprise Value | 0.50B | PEG | - | EPS next Q | -0.49 | Inst Own | 92.16% | Short Float | 4.82% | Perf Quarter | -32.77% |
| Income | -0.02B | P/S | 2.21 | EPS this Y | -41.57% | Inst Trans | -5.11% | Short Ratio | 3.45 | Perf Half Y | 12.35% |
| Sales | 0.34B | P/B | 1.61 | EPS next 5Y | 66.94% | ROA | -4.15% | Short Interest | 1.39M | Perf YTD | -34.29% |
| Book/sh | 15.86 | P/C | 2.54 | EPS past 3/5Y | 31.36% -8.93% | ROE | -5.21% | 52W High | -42.28% ($44.28) | Perf Year | 36.25% |
| Cash/sh | 10.07 | P/FCF | 26.82 | Sales past 3/5Y | 35.94% 40.6% | ROIC | -4.77% | 52W Low | 75.19% ($14.59) | Perf 3Y | 27.86% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -229.24% | Gross Margin | 68.66% | Volatility(W/M) | 3.87% 5.33% | Perf 5Y | -60.18% |
| Dividend TTM | - | EV/Sales | 1.45 | Sales Y/Y TTM | 3.66% | Oper. Margin | -12.44% | ATR (14) | 1.54 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 5.11 | EPS Q/Q | -125.03% | Profit Margin | -7.02% | RSI (14) | 26.88 | Recom | 1.12 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.26 | Sales Q/Q | 0.81% | SMA20 | -12.07% ($29.07) | Beta | 1.17 | Target Price | $48.5 |
| Payout | - | Debt/Eq | 0.08 | Earnings | 2000000 | SMA50 | -26.38% ($34.72) | Rel Volume | 0.61 | Prev Close | $25.32 |
| Employees | 883 | LT Debt/Eq | 0.07 | EPS/Sales Surpr. | 69.06% 8.91% | SMA200 | -6.69% ($27.39) | Avg Volume(3M) | 0.40M | Price | $25.56 |
| IPO | 2019/7/25 | Option/Short | Yes/Yes | Trades | 4258 | Volume | 245,490 | Change | 0.95% |
뉴스 로딩 중...